Brief: Aspira Women's Health- On June 1 Co Received A Deficiency Letter From Nasdaq
02/06/2022 14:19
June 2 (Reuters) - Aspira Women's Health Inc AWH.O :
* ASPIRA WOMEN'S HEALTH- ON JUNE 1 CO RECEIVED A DEFICIENCY
LETTER
FROM NASDAQ
* ASPIRA WOMEN'S HEALTH- NOTIFIED THAT CLOSING BID PRICE FOR
CO'S
COMMON STOCK WAS BELOW MINIMUM REQUIREMENT FOR CONTINUED
INCLUSION ON NASDAQ CAPITAL MARKET
Source: [https://bit.ly/3GJ0Ef9]
Further company coverage: AWH.O
Recent news on Aspira Women's Health
See all newsBrief: Aspira Women’S Health Announces Receipt Of Delisting Notification From Nasdaq
Brief: Aspira Women's Health On April 4, Enters Equity Purchase Agreement With Triton Funds
Brief: Aspira Women's Health Files For Offering Up To 50 Units, 50 Mln Pre-Funded Units
Brief: Aspira Women's Health Interim CFO John Kallassy Resigns
Brief: Aspira Women's Health Fails To Regain Nasdaq Compliance